FourThought Financial Partners LLC boosted its holdings in shares of Cigna Group (NYSE:CI - Free Report) by 61.2% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 17,805 shares of the health services provider's stock after buying an additional 6,760 shares during the quarter. FourThought Financial Partners LLC's holdings in Cigna Group were worth $5,858,000 at the end of the most recent quarter.
Several other large investors also recently added to or reduced their stakes in CI. Norges Bank purchased a new stake in Cigna Group during the fourth quarter valued at $867,785,000. T. Rowe Price Investment Management Inc. purchased a new stake in Cigna Group during the fourth quarter valued at $724,517,000. GAMMA Investing LLC raised its stake in Cigna Group by 58,799.0% during the first quarter. GAMMA Investing LLC now owns 1,774,626 shares of the health services provider's stock valued at $583,852,000 after purchasing an additional 1,771,613 shares in the last quarter. Two Sigma Advisers LP raised its stake in Cigna Group by 278.0% during the fourth quarter. Two Sigma Advisers LP now owns 816,200 shares of the health services provider's stock valued at $225,385,000 after purchasing an additional 600,300 shares in the last quarter. Finally, Voloridge Investment Management LLC raised its stake in Cigna Group by 400.9% during the fourth quarter. Voloridge Investment Management LLC now owns 643,253 shares of the health services provider's stock valued at $177,628,000 after purchasing an additional 514,841 shares in the last quarter. 86.99% of the stock is currently owned by institutional investors.
Cigna Group Price Performance
Cigna Group stock traded up $5.95 during trading on Wednesday, reaching $298.12. The company had a trading volume of 1,066,358 shares, compared to its average volume of 1,798,184. The firm's 50-day simple moving average is $311.29 and its 200 day simple moving average is $312.28. Cigna Group has a 1-year low of $262.03 and a 1-year high of $370.83. The firm has a market capitalization of $79.64 billion, a PE ratio of 16.52, a price-to-earnings-growth ratio of 0.88 and a beta of 0.44. The company has a debt-to-equity ratio of 0.65, a quick ratio of 0.72 and a current ratio of 0.72.
Cigna Group (NYSE:CI - Get Free Report) last announced its earnings results on Friday, May 2nd. The health services provider reported $6.74 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.35 by $0.39. Cigna Group had a net margin of 1.97% and a return on equity of 18.63%. The company had revenue of $65.45 billion for the quarter, compared to analysts' expectations of $60.39 billion. During the same quarter in the previous year, the company posted $6.47 EPS. The firm's quarterly revenue was up 14.4% on a year-over-year basis. As a group, equities research analysts anticipate that Cigna Group will post 29.77 earnings per share for the current fiscal year.
Cigna Group Announces Dividend
The business also recently declared a quarterly dividend, which will be paid on Thursday, September 18th. Stockholders of record on Thursday, September 4th will be issued a dividend of $1.51 per share. The ex-dividend date of this dividend is Thursday, September 4th. This represents a $6.04 annualized dividend and a dividend yield of 2.03%. Cigna Group's dividend payout ratio is presently 33.44%.
Wall Street Analysts Forecast Growth
A number of equities research analysts recently issued reports on the stock. Cowen reaffirmed a "buy" rating on shares of Cigna Group in a research note on Monday, May 5th. Wall Street Zen cut shares of Cigna Group from a "strong-buy" rating to a "buy" rating in a research report on Friday, July 18th. Mizuho boosted their price objective on shares of Cigna Group from $360.00 to $384.00 and gave the company an "outperform" rating in a research report on Wednesday, April 9th. Royal Bank Of Canada reiterated an "outperform" rating and set a $371.00 price objective on shares of Cigna Group in a research report on Thursday, June 26th. Finally, Guggenheim reiterated a "buy" rating and set a $388.00 price objective on shares of Cigna Group in a research report on Friday, May 23rd. Two investment analysts have rated the stock with a hold rating, seventeen have given a buy rating and two have assigned a strong buy rating to the company. According to MarketBeat.com, the stock presently has an average rating of "Buy" and an average price target of $380.39.
View Our Latest Stock Report on Cigna Group
About Cigna Group
(
Free Report)
The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.
See Also

Before you consider Cigna Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cigna Group wasn't on the list.
While Cigna Group currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.